Long-term safety and efficacy of rupatadine in Japanese patients with perennial allergic rhinitis: a 52-week open-label clinical trial

References

• Seidman MD, Gurgel RK, Lin SY. Clinical practice guideline: Allergic rhinitis executive summary. Otolaryngol Head Neck Surg. 2015;152:197–206.
   PubMed Web of Science ®Google Scholar
• Sibbald B, Rink E. Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history. Thorax. 1991;46:895–901.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy. 2008;63:8–160.
   PubMed Web of Science ®Google Scholar
• Zahradnik E, Raulf M. Animal allergens and their presence in the environment. Front Immunol. 2014;5:76.
   PubMed Web of Science ®Google Scholar
• Okubo K, Kurono Y, Ichimura K, et al. Japanese guidelines for allergic rhinitis 2017. Allergol Int. 2017;66:205–219.
   PubMed Web of Science ®Google Scholar
• Scadding GK, Durham SR, Mirakian R, et al. BSACI guidelines for the management of allergic and non-allergic rhinitis. Clin Exp Allergy. 2007;38:19–42.
   Web of Science ®Google Scholar
• Täubel J, Ferber G, Fernandes S, et al. Pharmacokinetics, safety and cognitive function profile of rupatadine 10, 20 and 40 mg in healthy Japanese subjects: a randomised placebo-controlled trial. PLoS One. 2016;11:e0163020.
   PubMed Web of Science ®Google Scholar
• Shamizadeh S, Brockow K, Ring J. Rupatadine: efficacy and safety of a non-sedating antihistamine with PAF-antagonist effects. Allergo J Int. 2014;23:87–95.
   PubMedGoogle Scholar
• Carceller E, Merlos M, Giral M, et al. [(3-Pyridylalkyl)piperidylidene]benzocycloheptapyridine derivatives as dual antagonists of PAF and histamine. J Med Chem. 1994;37:2697–2703.
   PubMed Web of Science ®Google Scholar
• Alfaro V. Role of histamine and platelet-activating factor in allergic rhinitis. J Physiol Biochem. 2004;60:101–111.
   PubMed Web of Science ®Google Scholar
• Shirasaki H, Seki N, Kikuchi M, et al. Expression and localization of platelet-activating factor receptor in human nasal mucosa. Ann Allergy Asthma Immunol. 2005;95:190–96
   PubMed Web of Science ®Google Scholar
• Ministry of Health, Labor and Welfare. Rheumatism and Allergy Countermeasure Committee Report. October 2005. Available at: http://www.mhlw.go.jp/shingi/2005/10/dl/s1031-6a.pdf. Accessed: June 14, 2015(in Japanese).
   Google Scholar
• World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Jama. 2013;310:2191–2194.
   PubMed Web of Science ®Google Scholar
• Ellis AK, Soliman M, Steacy L, et al. The Allergic Rhinitis – Clinical Investigator Collaborative (AR-CIC): nasal allergen challenge protocol optimization for studying AR pathophysiology and evaluating novel therapies. Allergy Asthma Clin Immunol. 2015;11(1):16.
   PubMedGoogle Scholar
• Okuda M, Ohkubo K, Goto M, et al. [Japanese Allergic Rhinitis Standard QOL Questionnaire (2002)]. Arerugi [Jpn J Allergol]. 2003;52:21–56 (in Japanese).
   PubMedGoogle Scholar
• Okuda M, Ohkubo K, Goto M, et al. Comparative study of two Japanese rhinoconjunctivitis quality-of-life questionnaires. Acta Otolaryngol. 2005;125:736–744.
   PubMed Web of Science ®Google Scholar
• International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). MedDRA® the Medical Dictionary for Regulatory Activities. A registered trademark of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA); Chantilly, VA: Northrop Grumman MSSO (distributors). 2019[March 13]. http://www.meddra.org/
   Google Scholar
• National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.03. 2019[March 13]. https://ctep.cancer.gov/protocoldevelopment/electronic_applications/ctc.htm#ctc_40
   Google Scholar
• Okubo K, Suzuki T, Tanaka A, et al. Efficacy and safety of rupatadine in Japanese patients with seasonal allergic rhinitis: A double-blind, randomized, multicenter, placebo-controlled clinical trial. Allergol Int. 2018;pii:S1323–S8930. 18)30119-9.
   Google Scholar
• Koinis-Mitchell D, Craig T, Esteban CA, et al. Sleep and allergic disease: a summary of the literature and future directions for research. J Allergy Clin Immunol. 2012;130:1275–1281.
   PubMed Web of Science ®Google Scholar
• Chiba S. [Nasal symptoms and sleep disorder in patients with allergic rhinitis]. Rinsho Meneki Arerugika [Clin Immunol Allergol] 2009;52:518–23 (in Japanese).
   Google Scholar
• Léger D, Annesi-Maesano I, Carat F, et al. Allergic rhinitis and its consequences on quality of sleep: An unexplored area. Arch Intern Med. 2006;166:1744–1748.
   PubMedGoogle Scholar
• Muliol J, Maurer M, Bousquet J. Sleep and allergic rhinitis. J Investig Allergol Clin Immunol. 2008;18:415–419.
   PubMed Web of Science ®Google Scholar
• Sur DK, Scandale S. Treatment of allergic rhinitis. Am Fam Physician. 2010;81:1440–1446.
   PubMed Web of Science ®Google Scholar
• Panigrahi R, Acharya SK. Recent trends in management of allergic rhinitis. Aijcr. 2016;9:130–136.
   Google Scholar
• Nayak AS, Schenkel E. Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis. Allergy. 2001; 56:1077–1080.
   PubMed Web of Science ®Google Scholar
• Mullol J, Bousquet J, Bachert C, et al. Update on rupatadine in the management of allergic disorders. Allergy. 2015;70:1–24.
   PubMed Web of Science ®Google Scholar
• Marmouz F, Giralt J, Izquierdo I. Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial. J Asthma Allergy. 2011;4:27–35.
   PubMedGoogle Scholar
• Colagiuri B, Morley K, Boakes R, et al. Expectancy in double-blind placebo-controlled trials: an example from alcohol dependence. Psychother Psychosom. 2009;78:167–171.
   PubMed Web of Science ®Google Scholar